AI assistant
Sending…
Onconetix, Inc. — Director's Dealing 2025
Mar 7, 2025
35411_dirs_2025-03-07_10f74f2a-d53b-4f88-9227-7ecd8c7974f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2025-02-24
Reporting Person: Oakley Andrew John (Director)
More from Onconetix, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Mar 30
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 9